NCT04374578View on ClinicalTrials.gov

Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

May 8, 2020

Primary Completion Date

January 31, 2021

Study Completion Date

June 30, 2021

Conditions
Type 2 Diabetes
Interventions
DRUG

Dulaglutide 1.5 MG/ML

Dulaglutide 1.5Mg qw sc injection for 4 weeks

Trial Locations (1)

200032

180 Fenglin Road, Shanghai

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER

NCT04374578 - Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter